We hypothesized that HVEM expression on hematopoietic tumor cells may serve as a cell extrinsic factor that can modulate the anti-tumor response by co-inhibiting the function of T cells and NK cells through BTLA. The gene discussed is TNFRSF14; the disease is neoplasm.